Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Parkinson's Disease

  Free Subscription


1 Exp Neurol
2 J Neural Transm (Vienna)
6 Mov Disord
1 Nat Rev Neurol
1 Neurobiol Dis
1 Neurology
1 Neuroscience
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Exp Neurol

  1. CHAO H, Liu Y, Fu X, Xu X, et al
    Lowered iPLA2gamma activity causes increased mitochondrial lipid peroxidation and mitochondrial dysfunction in a rotenone-induced model of Parkinson's disease.
    Exp Neurol. 2017 Nov 2. pii: S0014-4886(17)30291.
    PubMed     Text format     Abstract available

    J Neural Transm (Vienna)

  2. MARTINI A, Ellis SJ, Grange JA, Tamburin S, et al
    Risky decision-making and affective features of impulse control disorders in Parkinson's disease.
    J Neural Transm (Vienna). 2017 Nov 8. doi: 10.1007/s00702-017-1807.
    PubMed     Text format     Abstract available

  3. TITOVA N, Martinez-Martin P, Katunina E, Chaudhuri KR, et al
    Advanced Parkinson's or "complex phase" Parkinson's disease? Re-evaluation is needed.
    J Neural Transm (Vienna). 2017 Nov 7. doi: 10.1007/s00702-017-1799.
    PubMed     Text format     Abstract available

    Mov Disord

    Closing the celebration of 200 years of Parkinson's Essay on the Shaking Palsy: Where do we go in the next 200 years?
    Mov Disord. 2017 Nov 9. doi: 10.1002/mds.27214.
    PubMed     Text format    

  5. SCHNEIDER SA, Alcalay RN
    Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.
    Mov Disord. 2017;32:1504-1523.
    PubMed     Text format     Abstract available

    What would James Parkinson think? A virtual dialogue on factors influencing the development of Parkinson's disease.
    Mov Disord. 2017;32:1499-1500.
    PubMed     Text format    

    The cerebral basis of Parkinsonian tremor: A network perspective.
    Mov Disord. 2017 Nov 9. doi: 10.1002/mds.27224.
    PubMed     Text format     Abstract available

  8. BALCK A, Klein C
    Reduced penetrance of Leucine-rich repeat kinase 2 mutations: Discovering genetic factors of endogenous disease protection.
    Mov Disord. 2017;32:527.
    PubMed     Text format    

  9. ARNALDI D, De Carli F, Fama F, Brugnolo A, et al
    Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers.
    Mov Disord. 2017 Nov 9. doi: 10.1002/mds.27190.
    PubMed     Text format     Abstract available

    Nat Rev Neurol

  10. COMPTA Y, Marti MJ
    Parkinson disease: What goes around comes around: cognitive impairment as prodromal parkinsonism?
    Nat Rev Neurol. 2017 Nov 10. doi: 10.1038/nrneurol.2017.
    PubMed     Text format    

    Neurobiol Dis

  11. SPIGOLON G, Cavaccini A, Trusel M, Tonini R, et al
    cJun N-terminal kinase (JNK) mediates cortico-striatal signaling in a model of Parkinson's disease.
    Neurobiol Dis. 2017 Oct 28. pii: S0969-9961(17)30243.
    PubMed     Text format     Abstract available


  12. DODEL R
    beta-Amyloid pathology and Parkinson disease.
    Neurology. 2017 Nov 8. pii: 10.1212/WNL.0000000000004756.
    PubMed     Text format    


  13. ZAEHLE T, Wagenbreth C, Voges J, Heinze HJ, et al
    Effects of deep brain stimulation of the subthalamic nucleus on perceptual decision making.
    Neuroscience. 2017;343:140-146.
    PubMed     Text format     Abstract available

    PLoS One

  14. UCHINO K, Shiraishi M, Tanaka K, Akamatsu M, et al
    Impact of inability to turn in bed assessed by a wearable three-axis accelerometer on patients with Parkinson's disease.
    PLoS One. 2017;12:e0187616.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.